CRISPR Therapeutics AG (CRSP) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CRSP. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 510 institutions reported holding CRSP, with 76.2 million shares worth $4.2 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| ARK Invest | 9,460,939 | $516M | DECREASED |
| BlackRock | 8,348,977 | $455M | INCREASED |
| Capital Group | 6,029,639 | $329M | INCREASED |
| Orbis Allan Gray | 5,449,161 | $297M | DECREASED |
| State Street | 4,321,666 | $236M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Sivakesava Sakhamuri (Chief Technical Officer) | AWARD | 40,000 | 2026-11-04 | |
| Sivakesava Sakhamuri (Chief Technical Officer) | AWARD | 90,000 | $5M | 2026-11-04 |
| Naimish Patel (Chief Medical Officer) | AWARD | 12,000 | 2026-10-26 | |
| Naimish Patel (Chief Medical Officer) | AWARD | 24,000 | $1M | 2026-10-26 |
| Samarth Kulkarni (Chief Executive Officer) | AWARD | 28,750 | 2026-10-26 |
Full institutional holdings, insider history, and congressional trades for CRISPR Therapeutics AG on SentiSense.